(VIANEWS) – NMI Holdings (NMIH), R1 RCM (RCM), Grupo Aval Acciones y Valores S.A. ADR (AVAL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. NMI Holdings (NMIH)

25.1% sales growth and 14.11% return on equity

NMI Holdings, Inc., through its subsidiaries, provides private mortgage guaranty insurance services in the United States.

NMI Holdings’s sales growth this year is anticipated to be 17.5% and 17.2% for next year.

Year-on-year quarterly revenue growth grew by 7%, now sitting on 440.83M for the twelve trailing months.

Volume

Today’s last reported volume for NMI Holdings is 356530 which is 18.05% below its average volume of 435088.

NMI Holdings’s sales growth for the next quarter is 25.1%. The company’s growth estimates for the current quarter and the next is 48.9% and 23.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.11%.

Volatility

NMI Holdings’s last day, last week, and last month’s current intraday variation average was 1.55%, 2.17%, and 1.92%, respectively.

NMI Holdings’s highest amplitude of average volatility was 3.03% (day), 3.82% (last week), and 3.22% (last month), respectively.

NMI Holdings’s Stock Yearly Top and Bottom Value

NMI Holdings’s stock is valued at $19.95 at 05:22 EST, way under its 52-week high of $26.82 and above its 52-week low of $19.43.

NMI Holdings’s Moving Average

NMI Holdings’s worth is way under its 50-day moving average of $22.69 and way under its 200-day moving average of $22.98.

2. R1 RCM (RCM)

22.2% sales growth and 42.08% return on equity

R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States.

R1 RCM’s sales growth this year is expected to be 15.7% and 15.1% for next year.

Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 1.33B for the twelve trailing months.

Volume

Today’s last reported volume for R1 RCM is 475693 which is 51.64% below its average volume of 983666.

R1 RCM’s sales growth is a negative 0% for the current quarter and 22.2% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 0% and negative -56%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.08%.

Volatility

R1 RCM’s last day, last week, and last month’s current intraday variation average was 2.33%, 1.96%, and 1.19%, respectively.

R1 RCM’s highest amplitude of average volatility was 3.58% (day), 3.36% (last week), and 3.06% (last month), respectively.

R1 RCM’s Stock Yearly Top and Bottom Value

R1 RCM’s stock is valued at $24.05 at 05:22 EST, way under its 52-week high of $31.28 and way above its 52-week low of $18.71.

R1 RCM’s Moving Average

R1 RCM’s worth is above its 50-day moving average of $23.90 and above its 200-day moving average of $23.05.

3. Grupo Aval Acciones y Valores S.A. ADR (AVAL)

21.6% sales growth and 15.66% return on equity

Grupo Aval Acciones y Valores S.A. provides a range of financial services and products to public and private sector customers in Colombia and Central America.

Grupo Aval Acciones y Valores S.A. ADR’s sales growth this year is expected to be 16.3% and 8.1% for next year.

Year-on-year quarterly revenue growth grew by 16.9%, now sitting on N/A for the twelve trailing months.

Volume

Today’s last reported volume for Grupo Aval Acciones y Valores S.A. ADR is 59348 which is 50.31% below its average volume of 119444.

Grupo Aval Acciones y Valores S.A. ADR’s sales growth for the next quarter is 21.6%. The company’s growth estimates for the present quarter and the next is 100% and negative -5.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.66%.

Volatility

Grupo Aval Acciones y Valores S.A. ADR’s last day, last week, and last month’s current intraday variation average was 1.13%, 0.67%, and 1.10%, respectively.

Grupo Aval Acciones y Valores S.A. ADR’s highest amplitude of average volatility was 1.69% (day), 2.08% (last week), and 2.59% (last month), respectively.

Grupo Aval Acciones y Valores S.A. ADR’s Stock Yearly Top and Bottom Value

Grupo Aval Acciones y Valores S.A. ADR’s stock is valued at $5.32 at 05:22 EST, way under its 52-week high of $7.03 and higher than its 52-week low of $5.07.

Grupo Aval Acciones y Valores S.A. ADR’s Moving Average

Grupo Aval Acciones y Valores S.A. ADR’s worth is below its 50-day moving average of $5.70 and under its 200-day moving average of $5.82.

4. Vertex Pharmaceuticals (VRTX)

17.4% sales growth and 24.64% return on equity

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis.

Vertex Pharmaceuticals’s sales growth this year is expected to be 17.5% and 10.5% for next year.

Year-on-year quarterly revenue growth grew by 29%, now sitting on 7.13B for the twelve trailing months.

Volume

Today’s last reported volume for Vertex Pharmaceuticals is 1821510 which is 0.25% above its average volume of 1816870.

Vertex Pharmaceuticals’s sales growth is a negative 0% for the ongoing quarter and 17.4% for the next. The company’s growth estimates for the current quarter and the next is 15.9% and 24.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.64%.

Volatility

Vertex Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 2.19%, 2.05%, and 0.71%, respectively.

Vertex Pharmaceuticals’s highest amplitude of average volatility was 1.48% (day), 1.47% (last week), and 1.64% (last month), respectively.

Vertex Pharmaceuticals’s Stock Yearly Top and Bottom Value

Vertex Pharmaceuticals’s stock is valued at $212.61 at 05:22 EST, way under its 52-week high of $242.99 and way higher than its 52-week low of $176.36.

Vertex Pharmaceuticals’s Moving Average

Vertex Pharmaceuticals’s worth is way higher than its 50-day moving average of $184.35 and above its 200-day moving average of $200.51.

5. Illumina (ILMN)

13.6% sales growth and 11.86% return on equity

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis.

Illumina’s sales growth this year is expected to be 34% and 11.5% for next year.

Year-on-year quarterly revenue growth grew by 39.5%, now sitting on 4.28B for the twelve trailing months.

Volume

Today’s last reported volume for Illumina is 919774 which is 0.68% below its average volume of 926087.

Illumina’s sales growth for the next quarter is 13.6%. The company’s growth estimates for the ongoing quarter and the next is 10.8% and negative -33.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.86%.

Volatility

Illumina’s last day, last week, and last month’s current intraday variation average was 1.16%, 2.05%, and 1.87%, respectively.

Illumina’s highest amplitude of average volatility was 5.39% (day), 3.38% (last week), and 3.06% (last month), respectively.

Illumina’s Stock Yearly Top and Bottom Value

Illumina’s stock is valued at $378.87 at 05:22 EST, way under its 52-week high of $555.77 and way higher than its 52-week low of $341.03.

Illumina’s Moving Average

Illumina’s value is below its 50-day moving average of $391.10 and way below its 200-day moving average of $426.55.

Previous days news about Illumina(ILMN)

  • According to Benzinga on Tuesday, 14 December, "January 2019: PierianDx announced its partnership with Illumina to come up with informatics services such as oncology products for Illumina to support cancer diagnosis and research."

6. Evertec (EVTC)

5.8% sales growth and 41.27% return on equity

EVERTEC, Inc. engages in transaction processing business serving financial institutions, merchants, corporations, and government agencies in Latin America and the Caribbean.

Evertec’s sales growth this year is anticipated to be 13.7% and 5.8% for next year.

Year-on-year quarterly revenue growth grew by 6.9%, now sitting on 568.76M for the twelve trailing months.

Volume

Today’s last reported volume for Evertec is 133440 which is 54.11% below its average volume of 290788.

Evertec’s sales growth for the next quarter is 5.8%. The company’s growth estimates for the present quarter and the next is 5.1% and 6.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.27%.

Volatility

Evertec’s last day, last week, and last month’s current intraday variation average was 1.99%, 1.43%, and 1.78%, respectively.

Evertec’s highest amplitude of average volatility was 3.09% (day), 2.35% (last week), and 2.91% (last month), respectively.

Evertec’s Stock Yearly Top and Bottom Value

Evertec’s stock is valued at $48.23 at 05:22 EST, under its 52-week high of $51.06 and way higher than its 52-week low of $33.85.

Evertec’s Moving Average

Evertec’s worth is above its 50-day moving average of $45.60 and way higher than its 200-day moving average of $43.52.

7. Pepsico (PEP)

5.6% sales growth and 59.04% return on equity

PepsiCo, Inc. operates as a food and beverage company worldwide.

Pepsico’s sales growth this year is anticipated to be 9.4% and 4.1% for next year.

Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 74.58B for the twelve trailing months.

Volume

Today’s last reported volume for Pepsico is 5838150 which is 38.28% above its average volume of 4221840.

Pepsico’s sales growth for the next quarter is 5.6%. The company’s growth estimates for the ongoing quarter and the next is 4.2% and 6.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 59.04%.

Volatility

Pepsico’s last day, last week, and last month’s current intraday variation average was 1.69%, 1.05%, and 0.49%, respectively.

Pepsico’s highest amplitude of average volatility was 1.49% (day), 1.29% (last week), and 1.47% (last month), respectively.

Pepsico’s Stock Yearly Top and Bottom Value

Pepsico’s stock is valued at $171.82 at 05:22 EST, above its 52-week high of $169.12.

Pepsico’s Moving Average

Pepsico’s worth is higher than its 50-day moving average of $161.49 and way higher than its 200-day moving average of $151.82.

LEAVE A REPLY

Please enter your comment!
Please enter your name here